Annual Non Current Assets
$93.69 M
+$12.91 M+15.99%
31 December 2022
Summary:
Mirati Therapeutics annual long term assets is currently $93.69 million, with the most recent change of +$12.91 million (+15.99%) on 31 December 2022. During the last 3 years, it has risen by +$12.91 million (+15.99%).MRTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$93.63 M
-$2.50 M-2.60%
30 September 2023
Summary:
Mirati Therapeutics quarterly long term assets is currently $93.63 million, with the most recent change of -$2.50 million (-2.60%) on 30 September 2023.MRTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +16.0% | +15.9% |
| 5 y5 years | +1102.2% | +1101.4% |
MRTX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -2.6% |
Mirati Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $93.63 M(-2.6%) |
| June 2023 | - | $96.13 M(+1.8%) |
| Mar 2023 | - | $94.41 M(+0.8%) |
| Dec 2022 | $1.11 B(-26.5%) | $93.69 M(+21.2%) |
| Sept 2022 | - | $77.30 M(+0.6%) |
| June 2022 | - | $76.86 M(-1.7%) |
| Mar 2022 | - | $78.18 M(-3.2%) |
| Dec 2021 | $1.51 B(+7.4%) | $80.77 M(-0.9%) |
| Sept 2021 | - | $81.54 M(+5.1%) |
| June 2021 | - | $77.60 M(+0.4%) |
| Mar 2021 | - | $77.32 M(+6.7%) |
| Dec 2020 | $1.40 B(+230.7%) | $72.48 M(+196.3%) |
| Sept 2020 | - | $24.46 M(+146.7%) |
| June 2020 | - | $9.91 M(+14.9%) |
| Mar 2020 | - | $8.63 M(+10.8%) |
| Dec 2019 | $424.41 M(+87.2%) | $7.79 M(+28.8%) |
| Sept 2019 | - | $6.05 M(+5.3%) |
| June 2019 | - | $5.75 M(+92.9%) |
| Mar 2019 | - | $2.98 M(+66.1%) |
| Dec 2018 | $226.66 M(+45.5%) | $1.79 M(+12.5%) |
| Sept 2018 | - | $1.59 M(+0.3%) |
| June 2018 | - | $1.59 M(+8.2%) |
| Mar 2018 | - | $1.47 M(-1.1%) |
| Dec 2017 | $155.76 M(+161.5%) | $1.49 M(-44.1%) |
| Sept 2017 | - | $2.66 M(-1.7%) |
| June 2017 | - | $2.71 M(-4.7%) |
| Mar 2017 | - | $2.84 M(-27.0%) |
| Dec 2016 | $59.55 M(-52.5%) | $3.89 M(+5.9%) |
| Sept 2016 | - | $3.67 M(+24.3%) |
| June 2016 | - | $2.95 M(+13.5%) |
| Mar 2016 | - | $2.60 M(-0.5%) |
| Dec 2015 | $125.40 M(+284.0%) | $2.62 M(-0.9%) |
| Sept 2015 | - | $2.64 M(+169.1%) |
| June 2015 | - | $981.00 K(-1.2%) |
| Mar 2015 | - | $993.00 K(+20.8%) |
| Dec 2014 | $32.66 M | $822.00 K(-14.7%) |
| Sept 2014 | - | $964.00 K(+91.7%) |
| June 2014 | - | $503.00 K(+82.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $275.00 K(-14.6%) |
| Dec 2013 | $64.22 M(+63.3%) | $322.00 K(-67.1%) |
| Sept 2013 | - | $980.00 K(+62.3%) |
| June 2013 | - | $604.00 K(+0.2%) |
| Mar 2013 | - | $603.00 K(+27.8%) |
| Dec 2012 | $39.33 M(+29.6%) | $472.00 K(-26.6%) |
| Sept 2012 | - | $643.10 K(+3.7%) |
| June 2012 | - | $620.40 K(+2.3%) |
| Mar 2012 | - | $606.40 K(-2.2%) |
| Dec 2011 | $30.34 M(+212.5%) | $620.00 K(-34.8%) |
| Sept 2011 | - | $951.10 K(+3.5%) |
| June 2011 | - | $918.90 K(-25.0%) |
| Mar 2011 | - | $1.23 M(+2.1%) |
| Dec 2010 | $9.71 M(-48.7%) | $1.20 M(-20.8%) |
| Sept 2010 | - | $1.52 M(-18.2%) |
| June 2010 | - | $1.85 M(+41.2%) |
| Mar 2010 | - | $1.31 M(-36.7%) |
| Dec 2009 | $18.94 M(-49.8%) | $2.07 M(+25.5%) |
| Sept 2009 | - | $1.65 M(-1.1%) |
| June 2009 | - | $1.67 M(-3.3%) |
| Mar 2009 | - | $1.73 M(-14.3%) |
| Dec 2008 | $37.69 M(-44.9%) | $2.02 M(-54.6%) |
| Sept 2008 | - | $4.45 M(-7.8%) |
| June 2008 | - | $4.82 M(-3.4%) |
| Mar 2008 | - | $5.00 M(-8.7%) |
| Dec 2007 | $68.38 M(+12.4%) | $5.47 M(+1.8%) |
| Sept 2007 | - | $5.38 M(+3.0%) |
| June 2007 | - | $5.22 M(+6.0%) |
| Mar 2007 | - | $4.92 M(-0.5%) |
| Dec 2006 | $60.82 M(+145.4%) | $4.95 M(-7.8%) |
| Sept 2006 | - | $5.37 M(+0.5%) |
| June 2006 | - | $5.34 M(+3.3%) |
| Mar 2006 | - | $5.17 M(-3.1%) |
| Dec 2005 | $24.78 M(-32.1%) | $5.34 M(-4.4%) |
| Sept 2005 | - | $5.59 M(+3.2%) |
| June 2005 | - | $5.42 M(+13.7%) |
| Mar 2005 | - | $4.76 M |
| Dec 2004 | $36.52 M(+30.4%) | - |
| Dec 2003 | $28.00 M | - |
FAQ
- What is Mirati Therapeutics annual long term assets?
- What is the all time high annual non current assets for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Mirati Therapeutics?
What is Mirati Therapeutics annual long term assets?
The current annual non current assets of MRTX is $93.69 M
What is the all time high annual non current assets for Mirati Therapeutics?
Mirati Therapeutics all-time high annual long term assets is $93.69 M
What is Mirati Therapeutics quarterly long term assets?
The current quarterly non current assets of MRTX is $93.63 M
What is the all time high quarterly non current assets for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly long term assets is $96.13 M